2. Academic Validation
  3. Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine

Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine

  • J Cereb Blood Flow Metab. 2007 Jun;27(6):1142-51. doi: 10.1038/sj.jcbfm.9600418.
Byoung Joo Gwag 1,  Young Ae Lee,  Sun Young Ko,  Moon Jung Lee,  Doo Soon Im,  Bok Sun Yun,  Hyang Ran Lim,  Sun Mi Park,  Han Yeol Byun,  Sun Ju Son,  Hye Jin Kwon,  Ji Yoon Lee,  Jae-Young Cho,  Seok Joon Won,  Kee-Won Kim,  Young Min Ahn,  Ho Sang Moon,  Hae Un Lee,  Sung Hwa Yoon,  Ji-Hyun Noh,  Jun-Mo Chung,  Sung Ig Cho
Affiliations

Affiliation

  • 1 Neurotech Pharmaceuticals Co., Ajou University School of Medicine, Suwon, Gyeonggido, South Korea. bjgwag@ajou.ac.kr
PMID: 17106444 DOI: 10.1038/sj.jcbfm.9600418
Abstract

Excitotoxicity and oxidative stress mediate neuronal death after hypoxic-ischemic brain injury. We examined the possibility that targeting both N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity and oxidative stress would result in enhanced neuroprotection against hypoxic-ischemia. 2-Hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid (Neu2000) was derived from aspirin and sulfasalazine to prevent both NMDA neurotoxicity and oxidative stress. In cortical cell cultures, Neu2000 was shown to be an uncompetitive NMDA Receptor Antagonist and completely blocked free radical toxicity at doses as low as 0.3 micromol/L. Neu2000 showed marked neuroprotection in a masked fashion using histology and behavioral testing in two rodent models of focal cerebral ischemia without causing neurotoxic side effects. Neu2000 protected against the effects of middle cerebral artery occlusion, even when delivered 8 h after reperfusion. Single bolus administration of the drug prevented gray and white matter degeneration and spared neurologic function for over 28 days after MACO. Neu2000 may be a novel therapy for combating both NMDA receptor-mediated excitotoxicity and oxidative stress, the two major routes of neuronal death in ischemia, offering profound neuroprotection and an extended therapeutic window.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z